Drug shortages

Azacitidine Injection

Eugia US LLC · Unavailable · Reason: Demand increase for the drug

Current55150-393-01Oncology
Open FDA's page for this record
Update type
Reverified
Initial posting date
12/22/2020
Package NDC
55150-393-01
Generic name
Azacitidine Injection
Contact info
888-238-7880
Availability
Unavailable
Related info
On backorder. Recovery: TBD. Check wholesalers for inventory
Update date
11/19/2026
Dosage form
Injection
Presentation
Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)
Company name
Eugia US LLC
Shortage reason
Demand increase for the drug
Status
Current
Therapeutic category
Oncology
Harmonized identifiers (openFDA)
Application number
ANDA215066
Brand name
AZACITIDINE
Generic name
AZACITIDINE
Manufacturer name
Eugia US LLC
Product NDC
55150-393
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS, SUBCUTANEOUS
Substance name
AZACITIDINE
RxCUI
485246
SPL ID
e89b9510-86df-4095-b6d3-4eb05b613c4f
SPL set ID
ecd108bd-bb5f-4b2e-ad91-210fca452e9b
Package NDC
55150-393-01
Nui
N0000000233, N0000175595
Pharm class moa
Nucleic Acid Synthesis Inhibitors [MoA]
Pharm class epc
Nucleoside Metabolic Inhibitor [EPC]
UNII
M801H13NRU
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.